MYCOPLASMA GENITALIUM A PRACTICAL GUIDE

Size: px
Start display at page:

Download "MYCOPLASMA GENITALIUM A PRACTICAL GUIDE"

Transcription

1 MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1

2 ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE ANTIBIOTICS OFTEN MULTIPLE PRACTITIONERS ANTIBIOTIC RESISTANCE ACCESS TO TREATMENT TIMEFRAMES 2

3 MYCOPLASMA GENITALIUM A PRACTICAL GUIDE WHO TO TEST TESTS FROM WHERE WITH WHAT MANAGEMENT OF POSITIVE TESTS TREATMENT SEXUAL CONTACTS TEST OF CURE 3

4 BOTTOM LINE DOXYCYCLINE FIRST LINE FOR NON GONOCOCCAL URETHRITIS TALK TO LABORATORY PREVENTION REINFECTION - CONDOMS CAN BE FRUSTRATING ASK ADVICE MYCOPLASMA IS ONE OF THE CAUSES OF URETHRITIS 4

5 TESTING WHO SYMPTOMATIC RECURRENT OR PERSISTENT URETHRITIS PID NOT RESPONDED TO TREATMENT CERVICITIS NOT RESPONDED TO TREATMENT CONTACTS LAST 3/12 HOW URETHRAL FVU CERVICAL RECTAL BE VERY CLEAR ON LAB FORM WHAT YOU ARE REQUESTING 5 TEST OF CURE 3/52

6 6

7 MANAGEMENT OF POSITIVE TESTS TREATMENT 500MG OF AZITHROMYCIN DAY 1, THEN 250MG DAILY DAYS 2-5 IF ALREADY HAD AZITHROMYCIN MOXIFLOXACIN 400MG DAILY FOR 7 DAYS - SPECIAL AUTHORITY MACROLIDE RESISTANT MOXIFLOXACIN 400MG DAILY FOR 7 DAYS SPECIAL AUTHORITY APPLY FOR WAIVER 7

8 RE SPECIAL AUTHORITY APPLICATIONS. IF YOU HAVE ANY QUERIES REGARDING THE PROCESSING OF PAPER BASED OR DECLINED SPECIAL AUTHORITY APPLICATIONS, PLEASE CONTACT SECTOR SERVICES ON CALL TO DISCUSS FAST-TRACKING APPLICATION AND WAIVERS 8

9 MANAGEMENT OF POSITIVE TESTS DISCUSS CONDITION GIVE WRITTEN INFORMATION CONTACT TRACING 3/12 AVOID REINFECTION NO SEX UNTIL 1/52 POST TREATMENT THEN CONDOMS UNTIL NEG TOC 1/52 FOLLOW UP VISIT/CALL TOC 3/52 9

10 10

11 FOLLOW UP RESULTS 1/52 FOLLOW UP VISIT/CALL SYMPTOM RESOLUTION ADHERENCE TO TREATMENT CONTACT TRACING RISK REINFECTION REMIND RE NO SEX UNTIL 1/52 AFTER COMPLETION TREATMENT THEN CONDOMS UNTIL NEGATIVE TOC BOOK TOC IF NOT ALREADY DONE SO ADD TO RECALL SYSTEM TEST OF CURE 3/52 IF POSITIVE TREATMENT DEPENDS ON: PREVIOUS TREATMENTS? REINFECTION? RESISTANT 11

12 MANAGEMENT SEXUAL CONTACTS BE CLEAR CONTACT OF M. GENITALIUM WRITE IT / TEXT IT / PRINT IT!!!!!!! CONTACTS PENILE / VAGINAL / ANO-RECTAL 3/12 TEST? TREAT BEFORE RESULTS SYMPTOMATIC AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 ASYMPTOMATIC DEPENDS ON HISTORY EXPOSURE NO SEX WITH SEXUAL CONTACTS FROM THE LAST 3 MONTHS UNTIL 7 DAYS AFTER BOTH THE PATIENT AND ONGOING SEXUAL CONTACTS HAVE COMPLETED THEIR TREATMENT, THEN CONDOMS UNTIL BOTH NEGATIVE TOC 12

13 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 1 FROM ONSET SYMPTOMS 1/52 Urethral irritation Penile discharge, clear WHAT DO YOU DO? Background 2/7 ago penetrative penile anal no condom, partner, regular sexual contact 3/52 ago receptive penile anal, condom, regular sexual contact 3/12 ago, penetrative penile vaginal, condom STI screening 12/12 ago NAD Nil else of note O/E NAD except clear colourless fluid urethral meatus 13

14 TREATMENT URETHRITIS DOXYCYCLINE 100MG BD 1/52 DISCUSS DIAGNOSIS URETHRITIS TEST CHLAMYDIA AND GONORRHOEA NAAT PO PA FVU SEROLOGY HIV, SYPHILIS EXPLANATION OF WHAT TESTING FOR INCLUDING WINDOW PERIODS ETC DISCUSS + OFFER CONDOM NO SEX UNTIL 7/7 AFTER COMPLETED TREATMENT CHECK CONTACT DETAILS FOR TEST RESULTS DISCUSS CONTACT TRACING LAST 2/12 FOLLOW UP 1/52 14

15 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 3 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS DOXYCYCLINE 100MG BD 1/52 WHAT DO YOU DO? 2/52 TESTS NAD CALLED TO GIVE RESULTS, NO ANSWER, DIDN T REPLY TO MESSAGES 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC HAS FOLLOWED YOUR ADVICE EXAM NAD 15

16 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 3 FROM ONSET SYMPTOMS Persistent urethritis o Discuss possible causes including M.genitalium o Testing M. genitalium FVU, rectal swab, timeframe results other testing as guided by history and exam findings o Treatment o Azithromycin 500mg day 1, then 250mg days Metronidazole 400mg bd 1/52 o If already treated with Azithromycin 1g, Doxycycline 100mg bd 1/52 o Re reinfection + transmission no sex until 1/52 post completion treatment 16 CONDOMS o Contact tracing 3/12

17 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM WHAT DO YOU DO? 18

18 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM PLAN DISCUSS + GIVE WRITTEN INFO CHECK SYMPTOMS CONTACT TRACING ENSURE THEY KNOW ITS M.GENITALIUM DISCUSSION TRANSMISSION REINFECTION CONDOMS IF ASYMPTOMATIC TOC 3/52 19

19 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 8 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM ASYMPTOMATIC 6/52 TEST OF CURE 8/52 NEGATIVE M GENITALIUM 20

20 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM IF STILL HAS SYMPTOMS WHAT DO YOU DO? 21

21 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM IF STILL HAS SYMPTOMS MOXIFLOXACIN 400MG OD 7/7 WRITTEN INFO DISCUSSION TRANSMISSION REINFECTION CONTACT TRACING ENSURE THEY KNOW ITS M.GENITALIUM CONDOMS 1/52 FOLLOW UP TOC 3/52 22

22 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 NEGATIVE M GENITALIUM 23

23 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 POSITIVE M GENITALIUM SEEK ADVICE! 24

24 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 NEGATIVE M GENITALIUM BUT WHAT ABOUT THE CONTACTS?! 1. 2/7 AGO PENETRATIVE PENILE ANAL NO CONDOM, PARTNER, REGULAR SEXUAL CONTACT 2. 3/52 AGO RECEPTIVE PENILE ANAL, CONDOM, REGULAR SEXUAL CONTACT 3. 3/12 AGO, PENETRATIVE PENILE VAGINAL, CONDOM 26

25 INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSON HAS HAD DOXYCYCLINE, NO BETTER, NOW HAVING AZITHROMYCIN 500MG D1, 250MG DAY 2-5 THEY HAVE REGULAR PENILE ANAL SEXUAL CONTACT CONDOMLESS AWARE MG TESTING, NO RESULT YET SYMPTOMATIC URETHRITIS BARRIERS TO CONDOM USE CLEAR URETHRAL DISCHARGE MEATUS WHAT DO YOU DO? 27

26 INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSON HAS HAD DOXYCYCLINE, NO BETTER, NOW HAVING AZITHROMYCIN 500MG D1, 250MG DAY 2-5 THEY HAVE REGULAR PENILE ANAL SEXUAL CONTACT CONDOMLESS AWARE MG TESTING, NO RESULT YET SYMPTOMATIC URETHRITIS BARRIERS TO CONDOM USE CLEAR URETHRAL DISCHARGE MEATUS PLAN TEST FVU + RECTAL SWAB EPIDEMIOLOGICAL TREATMENT WITH AZITHROMYCIN 500MG OD, 250MG OD DAYS 2-5 ALSO REITERATE NO SEX RESISTANT BUGS CONDOMS (DONT FORGET CONSIDERING OTHER CAUSES URETHRITIS, STI TESTING, FOLLOW UP RESULTS ETC) \ 28

27 ASYMPTOMATIC CONTACT 7 WEEKS FROM START INDEX PERSONS SYMPTOMS ASYMPTOMATIC CONTACT WHAT WOULD YOU DO? REGULAR ANAL RECEPTIVE AND INSERTIVE, CONDOMS NOT HAD SEX WITH INDEX CASE 7/52 TEXT SAYING TREATED STI BEEN TESTED AND NAD, ANOTHER SAYING?MG 29

28 ASYMPTOMATIC CONTACT 7 WEEKS FROM START INDEX PERSONS SYMPTOMS ASYMPTOMATIC CONTACT REGULAR ANAL RECEPTIVE AND INSERTIVE NOT HAD SEX WITH INDEX CASE 7/52 TEXT SAYING TREATED STI BEEN TESTED AND NAD, ANOTHER SAYING?MG AZITHROMYCIN 5/7 PLAN - TEST AND WAIT - IF SYMPTOMATIC - AZITHROMYCIN 500MG DAY 1, 250MG DAYS ALSO USUAL CONSULTATION HAVE WITH CONTACTS, STI TESTING ETC 30

29 ASYMPTOMATIC CONTACT 10 WEEKS FROM START INDEX PERSONS SYMPTOMS 3 /12 AGO WHAT DO YOU DO? RECEPTIVE PENILE VAGINAL CONDOM NO SYMPTOMS EXAMINATION NAD 31

30 ASYMPTOMATIC CONTACT 10 WEEKS FROM START INDEX PERSONS SYMPTOMS 3 1/12 AGO RECEPTIVE PENILE VAGINAL X1 CONDOM NO SYMPTOMS PLAN - TEST AND WAIT - IF SYMPTOMATIC / INDICATIVE FINDINGS -? ANY MORE INFORMATION AVAILABLE RE TEST RESULTS AND TREATMENTS? - AZITHROMYCIN 500MG DAY 1, 250MG DAYS ALSO USUAL CONSULTATION HAVE WITH CONTACTS, STI TESTING ETC 32

31 MYCOPLASMA GENITALIUM A PRACTICAL GUIDE USE DOXYCYCLINE FOR PEOPLE WHO PRESENT WITH URETHRITIS THAT YOU DON T THINK IS CAUSED BY GONORRHOEA M.GENITALIUM TREATED WITH AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 MOXIFLOXACIN 400MG OD 7/7 SPEAK TO SPECIAL AUTHORITY TEAM CAN FASTTRACK AND DO WAIVERS FOR MACROLIDE RESISTANT TESTING KNOW HOW TO ORDER SPEAK TO YOUR LAB WHAT TO USE BE CLEAR ON THE LAB FORM BE MINDFUL OF THE TIMEFRAMES AND POTENTIAL DELAYS! PRESENTATIONS, TESTING, RESULTS, APPROVAL FOR MEDS, GETTING THE MEDS, TAKING THE MEDS.TESTS OF CURE AND CONTACT TRACING WITH RISKS REINFECTION AS WELL AS RESISTANCE WRITE MYCOPLASMA GENITALIUM DOWN / TEXT / PRINT INFO FOR PEOPLE SO CONTACTS CAN BE TESTED AND TREATED APPROPRIATELY ASK FOR ADVICE 33

32 REFERENCES NZ SHS WEBSITE EUROPEAN GUIDELINES MG BASHH URETHRITIS SPECIAL AUTHORITY FORMS 34

Management of NGU (Non-gonococcal urethritis)

Management of NGU (Non-gonococcal urethritis) Management of NGU (Non-gonococcal urethritis) First line Doxycycline 100mg po bd for 7 days (contra-indicated in pregnancy) Alternative regimens Azithromycin 1G po stat Azithromycin 500mg po stat, then

More information

STIs: Practical Aspects of Management

STIs: Practical Aspects of Management STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS

More information

Clinical Guidelines Update (aka Know Your NAATs)

Clinical Guidelines Update (aka Know Your NAATs) Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz

More information

Answers to those burning questions -

Answers to those burning questions - Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department

More information

Mycoplasma Genitalium: Get to Know the Hidden STI

Mycoplasma Genitalium: Get to Know the Hidden STI Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/womens-health-update/mycoplasma-genitalium-get-to-know-hiddensti/9501/

More information

Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE

Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE Overview Introduction to Mycoplasma genitalium Audit Objectives Standards Results Reflection AFPHM learning objectives

More information

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch Dr Edward Coughlan Clinical Director Christchurch Sexual Health Christchurch 16:30-17:25 WS #48: Mycoplasma Genitalium - The New Black 17:35-18:30 WS #58: Mycoplasma Genitalium - The New Black (Repeated)

More information

Testing, Treating and Managing STIs Dr Jean Irvine

Testing, Treating and Managing STIs Dr Jean Irvine Testing, Treating and Managing STIs Dr Jean Irvine 1 Chlamydia 2 3 Chlamydia: key facts Intracellular bacterial infection Sexually transmitted: Vaginal sex Anal sex?oral sex Most common bacterial STI in

More information

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing

More information

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Chlamydia Most frequently reported bacterial STI in the US In 2006, In U.S. 1,030,911 cases were reported. Estimated 2,291,000 infections in 14-39 year olds.

More information

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection A Elgalib, A Skingsley, O Dosekun, S Alexander, CYW Tong, JA White. Ali Elgalib Consultant in GUM/HIV

More information

CLINICAL MANAGEMENT OF STDS

CLINICAL MANAGEMENT OF STDS CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual

More information

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council STI & HIV screening in Primary Care Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council Outline Why Screen Advances in diagnostics how can we

More information

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic STI control Dr. Jane Morgan Hamilton Sexual Health Clinic Overview STI control in theory NZ s reality Where to from here? STI control framework R0=ßcD R0 = reproductive rate; the rate at which infection

More information

Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document

Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document Clinical STI/HIV Care Pathway assumes appropriate competency verified (flow chart and explanatory notes to be read together)

More information

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS Warning: contains sexual themes and references! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz Updates

More information

Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK

Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK Appendix 1 Model Assumptions All assumptions were confirmed and

More information

Non-gonococcal urethritis. Looking after your sexual health

Non-gonococcal urethritis. Looking after your sexual health Non-gonococcal urethritis Looking after your sexual health 2 3 Non-gonococcal urethritis Urethritis is inflammation (pain, redness or soreness) of the urethra (the tube that carries urine out of the body).

More information

Gynaecology. Pelvic inflammatory disesase

Gynaecology. Pelvic inflammatory disesase Gynaecology د.شيماءعبداألميرالجميلي Pelvic inflammatory disesase Pelvic inflammatory disease (PID) is usually the result of infection ascending from the endocervix causing endometritis, salpingitis, parametritis,

More information

STIs- REVISION. Prof A A Hoosen

STIs- REVISION. Prof A A Hoosen STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex

More information

Responsibilities in a sexual relationship - Contact tracing

Responsibilities in a sexual relationship - Contact tracing P a g e 1 Responsibilities in a sexual relationship - Contact tracing This activity has been designed increase student familiarity with the NSW Health Play Safe website. Suggested duration: 50-60 minutes

More information

Update on Sexually Transmitted Infections among Persons Living with HIV

Update on Sexually Transmitted Infections among Persons Living with HIV Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and

More information

Extragenital Gonorrhea and Chlamydia among MSM

Extragenital Gonorrhea and Chlamydia among MSM Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org

More information

STIs in Primary Care. Dr Eleanor Draeger 19 th January 2016

STIs in Primary Care. Dr Eleanor Draeger 19 th January 2016 STIs in Primary Care Dr Eleanor Draeger 19 th January 2016 Poli=cs! 2012! Health and Social Care act! Sexual Health commissioning moved to local authority! 2015! 200 million cuts to public health! 40%

More information

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB

More information

A healthy respect for Sexual Health. Dee Archbold CNC Princess Alexandra Sexual Health

A healthy respect for Sexual Health. Dee Archbold CNC Princess Alexandra Sexual Health 2018 A healthy respect for Sexual Health Dee Archbold CNC Princess Alexandra Sexual Health Princess Alexandra Sexual Health (PASH) Sexual health service for Metro South (estimated >1million residents and

More information

WHAT DO U KNOW ABOUT STIS?

WHAT DO U KNOW ABOUT STIS? WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections

More information

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and 1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship

More information

STDs and Hepatitis C

STDs and Hepatitis C STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk

More information

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided

More information

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the

More information

What's the problem? - click where appropriate.

What's the problem? - click where appropriate. STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female

More information

STI Diagnostics Redesign. HVS and Chlamydia Resource Pack

STI Diagnostics Redesign. HVS and Chlamydia Resource Pack Important! 1. This information is intended to support practitioners in the management of common sexual health problems and it is therefore essential that each doctor and nurse receives a copy. 2. Future

More information

Nothing to disclose.

Nothing to disclose. Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence

More information

ONLINE SUPPLEMENTARY MATERIALS: FILE 1

ONLINE SUPPLEMENTARY MATERIALS: FILE 1 ONLINE SUPPLEMENTARY MATERIALS: FILE 1 Clinical care pathways using chlamydia and gonorrhoea tests are evolving: point of care nucleic acid amplification tests may reduce genitourinary medicine service

More information

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.

More information

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018 New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with

More information

Sexually transmitted infections (in women)

Sexually transmitted infections (in women) Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:

More information

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.? BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection

More information

TRICHOMONAS VAGINALIS

TRICHOMONAS VAGINALIS TRICHOMONAS VAGINALIS What s New: There are no changes to this guideline. Introduction Trichomonas vaginalis (TV) is a flagellated protozoan that is a parasite of the genital tract. Due to site specificity,

More information

Challenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A

Challenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple

More information

Welcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts.

Welcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts. Welcome to: Coding Scenarios for STD Clinic Visits We will begin in a few minutes. There will be no sound until the webinar starts. Welcome to: Coding Scenarios for STD Clinic Visits You are using audio

More information

25/02/2016. New onset low abdominal pain in women of reproductive age. New onset low abdominal pain: why it matters?

25/02/2016. New onset low abdominal pain in women of reproductive age. New onset low abdominal pain: why it matters? New onset in women of reproductive age Dr Deborah Bateson Medical Director Family Planning NSW Chair Australasian Sexual Health Alliance why it matters? Can be fatal (consider ectopic pregnancy in all

More information

Disclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None

Disclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California

More information

STI Indicators by STI

STI Indicators by STI STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients

More information

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes

More information

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Selena Singh Guy s and St Thomas NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool Performance of ceftriaxone 500mgcontaining

More information

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology

More information

PrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV.

PrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV. PrEP in Scotland PrEP PrEP PrEP PrEP is a combination pill that prevents HIV. 1 Contents Introduction 3 What is PrEP 3 Who should take PrEP 4 Getting PrEP in Scotland 5 Side effects and interactions with

More information

Screening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016

Screening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016 Screening & Treating Chlamydia in Primary Care Wednesday, September 21, 2016 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary

More information

Sexual health screening

Sexual health screening Sexual health screening This guideline provides screening recommendations that are based on anatomy and is inclusive of genderaffirming surgeries and hormone therapy. All patients should be screened according

More information

Podcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43

Podcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National

More information

Sexually Transmitted Diseases

Sexually Transmitted Diseases Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures

More information

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs Outline MSM = (at least) 9 patients /day Management in MSM&TGpopulations OPASSPUTCHAROEN M.D. CHULALONGKORNUNIVERSITY BANGKOK, TH /HIV Recreational drugs ual fluidity and HIV Risk behavior AIDS Patient

More information

Clinical Cases from the STD Clinical Consultation Network

Clinical Cases from the STD Clinical Consultation Network Clinical Cases from the STD Clinical Consultation Network Christine Johnston STD TCG April 24, 2017 Last Updated: uwptc@uw.edu uwptc.org 206-685-9850 STD Clinical Consultation Network (STDCCN) Developed

More information

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 TOPICS FOR DISCUSSION What medical providers should know

More information

MG and PID. Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service

MG and PID. Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service MG and PID Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service MG and NGNCU Strong relationship between M. genitalium and NGNCU Taylor-Robinson et al. 2011 Clin. Micro. Rev;24(3):498 MG

More information

LET S TALK about Sticking with your treatment plan

LET S TALK about Sticking with your treatment plan LET S TALK about Sticking with your treatment plan HOW ONGOING HIV CARE HELPS YOU LIVE A LONGER AND HEALTHIER LIFE Your treatment plan is vital to your overall health (and to reducing HIV transmission)

More information

Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs)

Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs) Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs) Self-Advocacy Educator - Max Barrows Sex Educator - Katherine McLaughlin www.elevatustraining.com Sex Educator

More information

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type. Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,

More information

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report. Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family

More information

Learning Objectives. STI Update. Case 1 6/1/2016

Learning Objectives. STI Update. Case 1 6/1/2016 Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe

More information

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI. Friday, MARCH 20, 2015 STUDENT COPY

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI. Friday, MARCH 20, 2015 STUDENT COPY MHD II, Session VI, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI Friday, MARCH 20, 2015 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis

More information

Clinical Education Initiative URETHRITIS. Elizabeth Asiago-Reddy, MD

Clinical Education Initiative URETHRITIS. Elizabeth Asiago-Reddy, MD Clinical Education Initiative Support@ceitraining.org URETHRITIS Elizabeth Asiago-Reddy, MD 3/13/2017 Urethritis [video transcript] 00:00:07 - [Elizabeth] Thanks so much for having me and I'm sorry for

More information

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis

More information

STI 2016: Where We Need to Go

STI 2016: Where We Need to Go STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually

More information

Dermatologist Venereologist MD, PhD

Dermatologist Venereologist MD, PhD Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma

More information

X-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers

X-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in

More information

Sexually Transmi/ed Diseases

Sexually Transmi/ed Diseases Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human

More information

GP Perspective about prescribing PEP & PrEP

GP Perspective about prescribing PEP & PrEP GP Perspective about prescribing PEP & PrEP Dr Garsing Wong, Auckland Central Medical and Health Centre, 326/28 College Hill, Freemans Bay, Auckland 1011 akcentralmedical@gmail.com 09 360 0250 Disclosures

More information

Clinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP

Clinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP Clinical Education Initiative Support@ceitraining.org TITLE: UPDATE ON MSM SEXUAL HEALTH Speaker: Maureen Scahill, MS NP 1/25/2017 2/10/2017 Update on MSM Sexual Health [video transcript] 00:00:08 - [Maureen]

More information

SEXUALLY TRANSMITTED INFECTIONS (STIS)

SEXUALLY TRANSMITTED INFECTIONS (STIS) SEXUALLY TRANSMITTED INFECTIONS (STIS) CONTENTS Causes Prevention Methods of Transmission Decisions to Have Sexual Intercourse Signs and symptoms Screening Pop Quiz Diagnosis Management: Public Health

More information

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016 Sexually Transmitted Infection surveillance in Northern Ireland 2017 An analysis of data for the calendar year 2016 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:

More information

APPENDIX A SERVICE SPECIFICATION

APPENDIX A SERVICE SPECIFICATION Service Specification No. Service Authority Lead Provider Lead 2013/14 APPENDIX A SERVICE SPECIFICATION Participation in the Ruclear chlamydia and gonorrhoea screening programme (General practices) Period

More information

5/1/2017. Sexually Transmitted Diseases Burning Questions

5/1/2017. Sexually Transmitted Diseases Burning Questions Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial

More information

Partner Counseling and Referral Services

Partner Counseling and Referral Services Partner Counseling and Referral Services Presented at the Sexually Transmitted Disease (STD) Intensive Course Cleveland, OH June 22, 2012 Rhiannon Richman, MPH Infertility Prevention Project Coordinator

More information

Sexually Transmitted Diseases. Chlamydial. infection. Questions and Answers

Sexually Transmitted Diseases. Chlamydial. infection. Questions and Answers Sexually Transmitted Diseases Chlamydial infection Questions and Answers What is chlamydial infection? It is a sexually transmitted infection caused by the bacteria Chlamydia trachomatis, being one of

More information

Sexual Health reproduction in reference to treatment as/for prevention

Sexual Health reproduction in reference to treatment as/for prevention Sexual Health reproduction in reference to treatment as/for prevention The reasons for sexual reproductive health for PLHIV The number of people living with HIV (PLWH) continues to rise in the UK The increase

More information

University Health Services at CMU STI Awareness Month specials for students:

University Health Services at CMU STI Awareness Month specials for students: University Health Services at CMU STI Awareness Month specials for students: -Free condoms during April (10 per student) -Free walk-in rapid HIV testing April 22-27 (no appointment needed) -STI Screening

More information

That Other Chlamydia: Lymphogranulom a Venereum (LGV)

That Other Chlamydia: Lymphogranulom a Venereum (LGV) Clinical Education Initiative Support@ceitraining.org That Other Chlamydia: Lymphogranulom a Venereum (LGV) Speaker: Marguerite Urban, MD 4/4/2018 That Other Chlamydia: Lymphogranuloma Venereum (LGV) [video

More information

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY MHD II, Session 6, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6 Friday, MARCH 18, 2016 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis

More information

How to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP?

How to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP? 4 What is PrEP? 6 Who will benefit from PrEP? 7 Men (cis or trans) and trans women who have sex with men Partners of people living with HIV 8 Take the quiz: Is PrEP right for me? What are the options for

More information

Services for GLBTQ Youth

Services for GLBTQ Youth Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual

More information

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014 Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES

More information

Control and Prevention of Sexually Transmitted Infections; Chlamydia trachomatis. Dr Nathalie Broutet Department of Reproductive Health and Research

Control and Prevention of Sexually Transmitted Infections; Chlamydia trachomatis. Dr Nathalie Broutet Department of Reproductive Health and Research Control and Prevention of Sexually Transmitted Infections; Chlamydia trachomatis Dr Nathalie Broutet Department of Reproductive Health and Research Intervention Effects Level Levels at which STI have

More information

Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens. Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine

Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens. Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine 37 th Annual Sanford Black Hills Pediatric Symposium June 26,

More information

People with genital herpes require enough information and medication (when indicated) to self-manage their condition.

People with genital herpes require enough information and medication (when indicated) to self-manage their condition. Genital Herpes Summary of Guidelines Taken from: Guidelines for the Management of Genital Herpes in New Zealand 11th Edition - 2015 www.herpes.org.nz Genital Herpes Key Management Points Genital herpes

More information

STIs and BBVs. The facts

STIs and BBVs. The facts EASY ENGLISH STIs and BBVs Some people say sex germs The facts New words There may be words in this factsheet that are new to you and you may not know what they mean or you may be unsure what they mean.

More information

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL DISCLOSURE PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Dr. Feller does not have any actual or potential conflicts of interest to disclose and will not be discussing

More information

TDL Sexual Health 2019

TDL Sexual Health 2019 TDL Sexual Health 019 Sexual Health Screening services continue to become easier to access for everyone, with testing and results becoming available more quickly through both private, NHS clinics, and

More information

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures

More information

Professor Jonathan Ross

Professor Jonathan Ross SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received

More information

PARTICIPANT DIARY TREATMENT ALLOCATION: LACTIC ACID GEL

PARTICIPANT DIARY TREATMENT ALLOCATION: LACTIC ACID GEL PARTICIPANT DIARY TREATMENT ALLOCATION: LACTIC ACID GEL For site staff completion only: Participating Site: Participant Initials: Participant ID: Date of Randomisation: Allocated Treatment: Lactic Acid

More information

PARTICIPANT DIARY TREATMENT ALLOCATION: ORAL METRONIDAZOLE TABLETS

PARTICIPANT DIARY TREATMENT ALLOCATION: ORAL METRONIDAZOLE TABLETS PARTICIPANT DIARY TREATMENT ALLOCATION: ORAL METRONIDAZOLE TABLETS For site staff completion only: Participating Site: Participant Initials: Participant ID: Date of Randomisation: Allocated Treatment:

More information

Clinical Practice Objectives

Clinical Practice Objectives STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public

More information

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Jade Feller, PharmD PGY-1 Pharmacy Resident Iowa City Veterans Affairs Health Care System November 13, 2018 DISCLOSURE

More information

Update on Sexual Health: Screening, Diagnosing and Treating STIs

Update on Sexual Health: Screening, Diagnosing and Treating STIs Update on Sexual Health: Screening, Diagnosing and Treating STIs Dr Gila Metz Medical Director, Health Sexuality and Risk Reduction Unit Ottawa Public Health November 28, 2013 Objectives To review current

More information

LEARNING NATIONAL CURRICULUM. Herpes virus. This section aims to teach students how sexual activity can lead to the spread of microbes and disease.

LEARNING NATIONAL CURRICULUM. Herpes virus. This section aims to teach students how sexual activity can lead to the spread of microbes and disease. This section aims to teach students how sexual activity can lead to the spread of microbes and disease. Section 2.3, Sexually Transmitted Infections, teaches students how easily potentially harmful microbes

More information

PART 3: HOW TO PROVIDE STI TEST RESULTS

PART 3: HOW TO PROVIDE STI TEST RESULTS PART 3: HOW TO PROVIDE STI TEST RESULTS HOW TO PROVIDE STI TEST RESULTS When an individual receives a positive result, providers are required by law to provide treatment or refer the patient to treatment

More information

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active?

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active? Essential Sexual Health Questions to Ask Adults Ask all of your adult patients the sexual health questions on this card. They will help you assess the patient s level of sexual risk and determine whether

More information